Gilead Sciences Inc.

04/07/2021 | Press release | Distributed by Public on 04/07/2021 18:10

FDA Approves Trodelvy®, the First Treatment for Metastatic Triple-Negative Breast Cancer Shown to Improve Progression-Free Survival and Overall Survival